CLICK “CONTINUE” AT THE BOTTOM OF THE PAGE TO COMPLETE YOUR REGISTRATION TO JOIN US IN LONG BEACH, CA.

CAN’T MAKE IT TO LONG BEACH? CLICK “CONTINUE” AT THE BOTTOM OF THE PAGE AND SELECT THE LIVE STREAMING OPTION TO PARTICIPATE VIRTUALLY.

Friday, August 1, 2025
Buffet Dinner: 6:00 PM – 6:30 PM PT
Symposium: 6:30 PM – 8:00 PM PT

LIVE/LIVE STREAMING SYMPOSIUM

Long Beach Convention Center
300 East Ocean Boulevard, Long Beach, CA 
Meeting Room: 103
 

Faculty  

Arshad M. Khanani, MD, MA, FASRS
Clinical Professor
University of Nevada, Reno School of Medicine
Managing Partner, Director of Clinical Research, Director of Fellowship
Sierra Eye Associates
Reno, NV

Matthew R. Starr, MD
Assistant Professor of Ophthalmology
Residency Program Director
Mayo Clinic
Rochester, MN
 

Target Audience 

This activity has been designed to meet the educational needs of retina specialists, ophthalmologists, and other clinicians who are interested in the management of patients with retinal disease.

This program is not affiliated with or endorsed by the ASRS.
 

Educational Provider

This activity is provided by Paradigm Medical Communications, LLC.  
 

Supporter Acknowledgment 

This activity is supported by an educational grant from Genentech, a member of the Roche Group.
 

Program Overview

Join experts as they explore the nuances of newer agents that have the potential to overcome some of the limitations of first-generation anti-VEGF therapy (eg, suboptimal response, high injection burden), with a focus on data demonstrating their impact on biomarkers of disease activity. These data, alongside real-life case studies, will support expert insights and recommendations on current best practices for agent selection and dosing interval decisions in this field of growing options.
 

Learning Objectives

Upon completion of this activity, participants should be able to:

• Describe the role of elevated angiopoietin 2 on key clinical biomarkers of neovascular retinal disease activity that can be visualized in the clinic 
• Discuss data demonstrating the effects of second-generation therapies on key clinical biomarkers of neovascular retinal disease activity
• Individualize treatment decisions for patients with neovascular retinal diseases based on clinical biomarkers of disease activity

Agenda

6:00 PM PT – 6:30 PM PT: Registration and Complimentary Buffet Dinner
6:30 PM PT – 8:00 PM PT: Clinical Program

• Introduction
• Clinical Biomarkers of Disease Activity (Diabetic Macular Edema)
• Clinical Biomarkers of Disease Activity (Neovascular Age-Related Macular Degeneration)
• Summary and Q&A

Physician Accreditation Statement

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 

Physician Credit Designation Statement

Paradigm Medical Communications, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

PA Continuing Education 

PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education 

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 

Disclosure of Relevant Financial Relationships 

In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months. Disclosure information about relevant financial relationships with ineligible companies (if any) for anyone contributing to content development will be included in materials distributed at the time of the activity. 
 

CME Inquires

For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com.
 

Fee Information

There is no fee required for participation in this activity.

Click the "Register Now" button. Once registered, you will receive an email confirmation with the event details.

© 2025 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.